En Es
Categories

Access Bio Inc

Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The company’s core in vitro diagnostic technology includes immunochemical, biochemical and molecular product ...
Products Covid-19Summary
Close

Covid-19 Access Bio Inc

Clinical Laboratory

COVID 19 IgM/IgG Test
CareStart COVID-19 IgM/IgG

The CareStart COVID-19 IgM/IgG Rapid Diagnostic Test for the Detection of SARS-CoV-2 IgM/IgG Ab provides a fast and easy diagnostic tool for COVID-19 in the limited testing environment. It detects and differentiates IgM/IgG antibody specific to SARS-CoV-2 using a small sample volume of 10 uL of venous whole blood, serum, or plasma) with results available in 10 minutes.
More details

COVID-19 RT-PCR Test
CareStart COVID-19 MDx RT-PCR

The CareStart COVID-19 MDx RT-PCR is intended for qualitative detection of SARS-CoV-2 RNA in upper respiratory specimens (such as and nasopharyngeal wash/aspirate or nasal aspirate) and bronchoalveolar lavage from individuals suspected of COVID-19 by their healthcare provider. The FDA emergency use authorized test has a processing time of less than 83 minutes and is available for use with the CFX96 system (Bio-Rad Laboratories, Inc.) and Applied Biosystems 7500/7500 Fast Real-Time PCR System (Thermofisher Scientific).
More details

COVID-19 Antigen Test
CareStart COVID-19 Antigen Test

The CareStart COVID-19 Antigen Test is an intended point-of-care (POC) designated test with a 10 minute processing time that allows effective screening of COVID-19 infection on a large scale. The lateral flow assay provides rapid results in 10 minutes using minimally invasive specimen collection (nasopharyngeal) and is intended for use at POC settings (i.e., in patient care settings) by medical professionals.
More details

SARS-CoV-2 RT-PCR Test
CareGene N-CoV RT-PCR Kit

The CareGene N-CoV RT-PCR Kit is an in vitro diagnostic medical device for the qualitative detection of COVID-19 from RNA extracted from human Nasopharyngeal swab, Oropharyngeal swab and sputum using Real Time-PCR. It targets two regions of viral RNA (N gene and RdRP gene), with both the reverse transcription (RT) and qPCR step conducted in the same reaction well and has a reaction time of less than 83 minutes.
More details
Close

About Access Bio Inc

Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The company’s core in vitro diagnostic technology includes immunochemical, biochemical and molecular products.
FaceBook Twitter Google+ Linked in
Neonatal Analyzer

Neonatal Analyzer

Model: CareStart S1 Analyzer
Request Information

Description:

The CareStart S1 Analyzer is a neonatal solution that is capable of quantifying total G6PD, Hemoglobin, and Bilirubin levels. The analyzer's handheld format along with Bluetooth and other technologies enables patient-side accuracy and convenience.

Features

Features

- Increase workflow efficiency with rapid and reliable results
- No requirement for pretreatment or manual step
- Tiny volume of whole blood specimen (Capillary available)
- Short turnaround time within 4 minutes
- User-friendly interface design Request Information

Send A Message To This Supplier

* Required Information
* Email
To
Access Bio Inc (Neonatal Analyzer)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions